Completed
A Phase 2/3 Study of TVP-1012 at 0.5 mg or 1 mg in Levodopa Treated Parkinson's Disease Participants
NCT02337738
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
- Locations
-
- Nagoya, Aichi-ken, Japan
- Matsuyama, Ehime, Japan
- Touon, Ehime, Japan
- Kitakyushu, Fukuoka, Japan